ASRS
RYTM icon

Arizona State Retirement System’s Rhythm Pharmaceuticals RYTM Stock Holding History

Arizona State Retirement System’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Sell
15,073
-508
-3% -$45.9K 0.01% 885
2026
Q1 		$1.36M Sell
15,581
-181
-1% -$17.6K 0.01% 927
2025
Q4 		$1.69M Buy
15,762
+148
+0.9% +$15.7K 0.01% 836
2025
Q3 		$1.58M Buy
15,614
+1,780
+13% +$165K 0.01% 911
2025
Q2 		$874K Buy
13,834
+653
+5% +$40K 0.01% 1167
2025
Q1 		$698K Sell
13,181
-106
-0.8% -$5.88K ﹤0.01% 1250
2024
Q4 		$744K Buy
13,287
+119
+0.9% +$6.57K ﹤0.01% 1282
2024
Q3 		$690K Buy
13,168
+541
+4% +$25.9K ﹤0.01% 1312
2024
Q2 		$518K Sell
12,627
-366
-3% -$14.6K ﹤0.01% 1406
2024
Q1 		$563K Buy
12,993
+267
+2% +$11.7K ﹤0.01% 1368
2023
Q4 		$585K Sell
12,726
-224
-2% -$7.07K ﹤0.01% 1357
2023
Q3 		$297K Buy
12,950
+199
+2% +$4.46K ﹤0.01% 1670
2023
Q2 		$210K Sell
12,751
-310
-2% -$5.6K ﹤0.01% 1933
2023
Q1 		$233K Buy
13,061
+1,612
+14% +$40.5K ﹤0.01% 1851
2022
Q4 		$333K Buy
11,449
+1,178
+11% +$30.3K ﹤0.01% 1607
2022
Q3 		$252K Buy
10,271
+41
+0.4% +$762 ﹤0.01% 1745
2022
Q2 		$42K Buy
+10,230
New +$56K ﹤0.01% 2213
2021
Q2 		– Sell
-10,027
Closed -$213K – 2241
2021
Q1 		$213K Buy
10,027
+2,986
+42% +$86.6K ﹤0.01% 2010
2020
Q4 		$209K Buy
+7,041
New +$179K ﹤0.01% 1933

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arizona State Retirement System's RYTM Position: Q2 2026 in Review

Arizona State Retirement System reduced its Rhythm Pharmaceuticals (RYTM) stake by 3.3% in Q2 2026, selling an estimated $45.9K and leaving 15,073 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #885.

Arizona State Retirement System first reported a position in RYTM in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.69M in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Arizona State Retirement System held 15,073 shares of Rhythm Pharmaceuticals worth $1.67M as of Q2 2026.
  • Arizona State Retirement System sold 508 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $45.9K.
  • Rhythm Pharmaceuticals made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #885 holding.
  • Arizona State Retirement System first reported a position in Rhythm Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
  • Arizona State Retirement System's Rhythm Pharmaceuticals position peaked at $1.69M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.